RSNA 2003 

Abstract Archives of the RSNA, 2003


M05-0

Hot Topic: Universal Use of Non-ionic CT Contrast Material: Assessment of Incidence and Main Risk Factors

Scientific Papers

Presented on December 3, 2003
Presented as part of M05: Genitourinary (Genitourinary Imaging: Urinary Tract Calculi)

Participants

Maria Raquel Oliva MD, PRESENTER: Nothing to Disclose

Abstract: Abstract #800059 Russ savage 2 11 2003-11-14T16:03:00Z 2003-11-14T16:03:00Z 1 309 1765 United Stationers Supply Co., 14 3 2167 9.3821 2.85 pt 2 Purpose: CT contrast reactions are currently one of the main concerns of quality of care in Radiology. The objective of the present study was to determine the incidence of adverse reactions caused by universal use of a non-ionic CT contrast agent and to assess the associated risk factors. Methods and Materials: A two years (6/2001 – 5/2003) prospective study was conducted in a large urban teaching hospital and included all consecutive patients (n=29,508) that underwent contrast-enhance CT after intravenous injection of Iopromide at an iodine concentration of either 300 mgI/ml or 370 mgI/ml. Variables assessed included (i) patients gender and age, (ii) medical history pertaining to allergies and risk factors, (iii) patient admission status (out-patient, in-patient, ED), (iv) dose of contrast agent, (v) clinical type of reaction, (vi) severity of reaction and (vi) treatment provided. Descriptive analyses of the variables, comparisons of means and proportions using T-Student and Chi-Square tests were conducted. Results: The incidence of contrast reactions was 0.7% (211/29,508): 75.3% (159) in females and 24.7% (52) in males. The average age was 50.5 year (SD 15y). Dermal reactions (n=161) were the most frequent (77%). The reactions were classified as mild in 89% (n=188), moderate in 9% (n=19) and severe in 2% (n=4). 42% (89/211) of the patient required medical treatment. History of allergy was present in 43.6% (92/211) of patients while 13.7% (29/211) had documented prior contrast reactions. There were no statistically significant differences in the number of reactions depending on the dose of contrast agent administered (p=.350) and age of the patients (p=.089). The analysis showed that females (p<.001) and outpatients (p<.001) had statistically significant greater incidence of reactions. Conclusions: The incidence of CT contrast reactions with universal use of non-ionic contrast was less than 1%, within the current quality standard range (0.4%-3.1%). Females and outpatients had a significant higher incidence of contrast reactions. Importantly, contrast dose and patients age did not affect the incidence.

Cite This Abstract

Oliva MD, M, Hot Topic: Universal Use of Non-ionic CT Contrast Material: Assessment of Incidence and Main Risk Factors.  Radiological Society of North America 2003 Scientific Assembly and Annual Meeting, November 30 - December 5, 2003 ,Chicago IL. http://archive.rsna.org/2003/3800059.html